Fresh Tracks Therapeutics...

NASDAQ: FRTX · Real-Time Price · USD
0.94
0.00 (0.00%)
At close: Feb 28, 2025, 12:19 PM

Fresh Tracks Therapeutics Revenue

Fresh Tracks Therapeutics reported an annual revenue of $8.01M, reflecting a 15.31% growth. For the quarter ending December 31, 2023, Fresh Tracks Therapeutics generated $0 in revenue.
Revenue (ttm)
$8.01M
Revenue Growth
15.31%
Price / Sales Ratio
0.65
Revenue / Employee
$2M
Employees
4
Market Cap
5.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.